WuXi
WuXi begins US plant
May 2, 2014Manufacturing and Production CMO, China, NY, Shanghai, US, WuXi, pharmatech
Contract manufacturing organisation WuXi PharmaTech has begun work on a new facility in Philadelphia’s Navy Yard for the production of …
MedImmune signs China deal
September 11, 2012Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, China, MedImmune, WuXi, emerging markets, rheumatoid arthritis
MedImmune has sealed a joint venture with Shanghai-based WuXi AppTec to develop a novel biologic for autoimmune and inflammatory diseases …
Contract research news in brief
September 4, 2012Research and Development CRO, Charles River, WuXi
Charles River Laboratories (CRL) has paid $17 million for Accugenix, a company which provides endotoxin detection and microbial identity testing …
WuXi continues strong growth
August 14, 2012Manufacturing and Production China, WuXi
Chinese contract research firm Wuxi saw its revenue grow strongly in the second quarter, with its laboratory services playing a …
Charles River calls a halt to WuXi merger plans
August 4, 2010Research and Development Charles River Laboratories, WuXi
Charles River Laboratories has terminated its $1.6 billion agreement to acquire Chinese contract research organisation WuXi PharmaTech after an investor …
Contract research news in brief
July 13, 2010Research and Development Charles River Laboratories, ClinTec, ICON, Quintiles, Synexus, Technical Resources International, WuXi
Charles River places its proposal to merge with China’s WuXi PharmaTech in front of its shareholders, while ClinTec and Synexus …
WuXi posts buoyant increases in revenue and profit
May 13, 2010Research and Development CRO, Charles River, Charles River Laboratories, WuXi
China’s WuXi PharmaTech has given would-be purchaser Charles River Laboratories a lift after posting buoyant increases in both revenues and …
Charles River to buy WuXi for $1.6bn
April 27, 2010Research and Development Charles River, Charles River Laboratories, WuXi, contract research
Contract research and laboratory supplies giant Charles River has said it intends to purchase Chinese counterpart WuXi PharmaTech in a …
WuXi’s growth slows
March 17, 2010Research and Development CRO, China, WuXi
WuXi Pharmatech, one of China’s leading contract research organisations, has been motoring ahead in recent quarters while its western counterparts …
